Elequin Capital’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,595
Closed -$58.2K 172
2025
Q2
$58.2K Sell
1,595
-667
-29% -$24.2K 0.01% 254
2025
Q1
$87.4K Buy
+2,262
New +$89.7K 0.01% 143
2023
Q4
Sell
-4,433
Closed -$174K 379
2023
Q3
$174K Sell
4,433
-4,798
-52% -$191K 0.03% 113
2023
Q2
$375K Buy
+9,231
New +$380K 0.19% 59
2023
Q1
Sell
-1,734
Closed -$75.6K 340
2022
Q4
$75.6K Buy
+1,734
New +$73.7K 0.02% 278

Other funds holding BME

Elequin Capital's BME Position: Q3 2025 in Review

Elequin Capital sold out of BlackRock Health Sciences Trust (BME) in Q3 2025, closing a stake of 1,595 shares — an estimated $58.2K sold.

Elequin Capital first reported a position in BME in Q4 2022 and held it in 5 quarters. The position peaked at $375K in Q2 2023. 76 funds tracked by Wall St. Rank hold BME as of Q3 2025.

  • Elequin Capital reported no remaining BlackRock Health Sciences Trust position as of Q3 2025 after selling out during the quarter.
  • Elequin Capital sold 1,595 BlackRock Health Sciences Trust shares in Q3 2025, an estimated $58.2K.
  • Elequin Capital first reported a position in BlackRock Health Sciences Trust in Q4 2022 and held it in 5 quarters.
  • Elequin Capital's BlackRock Health Sciences Trust position peaked at $375K in Q2 2023.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2025.

Based on Elequin Capital's 13F filing for Q3 2025, filed 14 Nov 2025.